Inez De Greef

Biography

 Inez de Greef is a pharmaceutical professional with extensive experience with the pharma and biotech industry and has in-depth knowledge of the different elements of drug development and the interfaces between them. In 2013 she was appointed as CEO for Treeway. In 2010, Inez de Greef founded 3D-PharmXchange, a consultancy firm providing integrated and immediate drug development and project management solutions to biotech and pharma companies. Prior to that, she was subsequently Director Clinical Development and COO of Kinesis Pharma. She also has worked several years on clinical and clinical pharmacology projects in several therapeutic areas, e.g. CNS-related diseases. At Tibotec-Virco, she was clinical pharmacology lead for the successfully approved HIV protease inhibitor Prezistra and follow-up compounds. At Leiden Advanced Experts on PK and PD (LAP&P) she was responsible for modeling & simulation projects and project management. Inez has a training in Medical Biology from the University of Amsterdam, the Netherlands, and obtained her PhD at the department of Pharmacology of the LACDR, Leiden University, with her thesis ‘P-glycoprotein mediated transport across the blood-brain barrier.

Research Interest

 Pharma and Buisness